PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.\', \'Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas.\', \'Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Internal Medicine, Karpagam Faculty of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.\', \'Department of Internal Medicine, Ochsner Medical Center, New Orleans, Louisiana.\', \'Department of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/jmv.26338
?:doi
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 32706390
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
?:title
  • The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32706390>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32706390>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all